OICR – Dr. Gyawali receives salary support from the Ontario Institute for Cancer Research, funded by the government of Ontario.
MOHCCN – Dr. Gyawali’s research on precision oncology drug approval and reimbursement in Canada is funded by the Marathon of Hope Cancer Centres Network Patient Voices in Research Initiative.
Dr. Bishal Gyawali 